Delivery Order SPE2DB22D3501-SPE2DB24FVN21

Award Date 5/3/24
Potential Completion Date 5/6/24
Potential Value $2.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $7,002.20, is for the delivery of Mounjaro 12.5 mg/0.5 mL pens. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 17, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Mounjaro 12.5 mg/0.5 ml pens. The $2,034.92 firm fixed-price delivery order is for products to be delivered by May 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Mounjaro 15 mg/0.5 ml pens. The delivery order contract, valued at $2,659.20, is a firm fixed-price agreement with a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,930.20, is for the delivery of Mounjaro 10 mg/0.5 ml pens. This is a firm fixed-price delivery order contract with a period of performance through July 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,765.25, is for the delivery of Mounjaro 2.5 mg/0.5 ml pens. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of September 10, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of Mounjaro 7.5 mg/0.5 ml pens to the U.S. government. The contract, valued at $30,363.92, was awarded by the Defense Logistics Agency (DLA) and has a completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $3,156.00, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen, a major pharmaceutical distribution company, also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Mounjaro 7.5 mg/0.5 ml pens. The contract, valued at $26,845.60, is a Delivery Order with a Firm Fixed Price. It does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,593.70, is for the delivery of Mounjaro 7.5 mg/0.5 ml pharmaceutical pens. The contract does not have a set-aside designation, indicating open competition. It is a delivery order contract with a firm fixed-price pricing type, with an ultimate completion date of October 29, 2024. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 10 mg/0.5 ml pens. The contract is a delivery order with a firm fixed price of $1,511.03 and a completion date of May 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVN21
    Delivery Order

The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $2,630.00 fixed-price delivery order is for the supply of Mounjaro 7.5 mg/0.5 ml pens, with a performance period ending on May 6, 2024.

Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 8/2/24, 10:09 AM